ArticleCureus2026
Closing the Evidence-Practice Gap: A Quality Improvement Audit of Antibiotic Prescribing Following Incision and Drainage of Superficial Skin, Pilonidal and Perianal Abscesses.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Superficial abscesses are a common presentation to emergency and surgical services, typically managed with incision and drainage (I&D). For superficial skin abscesses, evidence suggests that adjunctive antibiotic therapy reduces treatment failure and recurrence, whereas the benefit in perianal abscesses remains less certain; in either case, prescribing practices remain inconsistent. At an Australian metropolitan teaching hospital, a baseline audit revealed poor adherence to local antibiotic prescribing guidelines following I&D of superficial skin and perianal abscesses, with variability in both antibiotic choice and duration. Method A retrospective audit of antibiotic prescribing in 49 patients undergoing I&D of superficial skin, pilonidal or perianal abscesses over a six-week period was performed. Patients with systemic infection or sepsis precluding immediate discharge, recurrent abscesses, deep-space extension, or those requiring drain insertion were excluded. Educational interventions were then implemented, including dissemination of a concise prescribing guideline via posters, email communication, and an in-person departmental meeting. A re-audit over the following six weeks was subsequently conducted; 59 patients met the inclusion criteria. Results A total of 108 patients were included across both audit cycles (49 pre-intervention, 59 post-intervention). Pre-intervention, 7/49 patients (14.3%) received guideline-concordant antibiotic therapy, indicating significant under-prescribing relative to local guidelines at baseline. Following the educational intervention, this increased to 24/59 patients (40.7%), representing an absolute improvement of 26.4 percentage points (95% CI: 10.5 to 42.3; χ²=9.11, p=0.0025). Although the confidence interval is wide, reflecting the modest sample size, it excludes no effect and is consistent with a clinically meaningful improvement in prescribing behaviour. It is notable, however, that 35/59 patients (59.3%) still did not receive guideline-concordant therapy following the intervention, underscoring that substantial room for improvement remains. Conclusion A simple educational intervention was associated with a clinically meaningful improvement in guideline-concordant antibiotic prescribing following abscess drainage, though the 70% compliance target was not reached, highlighting the limits of single-cycle educational initiatives in achieving full guideline concordance. For superficial skin abscesses, the evidence base is robust and efforts to embed guideline awareness into clinical practice are justified. For perianal abscesses, the evidence remains conflicting, and further high-quality trial data are needed before definitive prescribing recommendations can be made.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.